Month: December 2025

Relapses in people with relapsing-remitting multiple sclerosis (MS) may be more common in spring and summer, coinciding with warmer temperatures, low humidity, and greater fluctuations in atmospheric pressure, according to a study from Poland. Stressful life events and infections were the most frequent potential relapse triggers, the study found. “Better recognition of these issues within…

When I checked into the hospital last month, I answered all the usual diagnostic questions, but then one caught me off guard. A social worker asked if I had an advance directive in place. My first thought was to wonder just how bad the lab results were since I hadn’t seen them yet, but I…

In people with progressive multiple sclerosis (MS), treatment with the antioxidant lipoic acid did not improve walking or lessen other symptoms, such as fatigue, but it did show signs of slowing brain atrophy, or the loss of brain tissue. According to the researchers, this suggests possible positive biological effects from the antioxidant’s use, despite no…

An enzyme called CEMIP could be a target for small-molecule inhibitors that aim to promote myelin repair in people with multiple sclerosis (MS) and other conditions marked by myelin loss, a study found. Researchers discovered that CEMIP, which is elevated in areas of inflammatory nerve damage in people with MS, produces numerous hyaluronic acid molecules…

Myelin, the protective coating that helps nerve signals travel quickly and efficiently, also plays a key role in the precise timing of communication between brain cells, a new study from scientists in the Netherlands shows. In a mouse model, the researchers found that the loss of myelin disrupted the coordination of signals between different brain…

By Stacie Prada December is the perfect time to reflect on how the past year measured up to hopes and goals. In January, I created a 2025 Bingo card that reflected various priorities I have. It proved useful and motivating … Continue reading → Source: blog.mymsaa.org

A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more tolerable for people with multiple sclerosis (MS) and other neurological conditions is enrolling participants at Clermont-Ferrand University Hospital in France.  The study’s protocol was published in PLOS One, in a paper titled, “Musical intervention to reduce stress during botulinum toxin injection…